AIDS Weekly articles from November 2002

AIDS Weekly archives from November 2002

Specific effector activity reduces infection risk.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Canada have confirmed that HIV-specific T-cell activity reduces the risk of infection after exposure to the virus. George Makedonas and...

New York veterans suffer high rates of hepatitis C with HIV infection.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Veterans in New York have an alarmingly high rate of hepatitis C and HIV infection, researchers say. Norbert Brau and colleagues at Veterans Affairs Medical...

Hepatitis C virus speeds progression in HIV patients on antiretrovirals.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The authors of an Italian study believe hepatitis C virus (HCV) coinfection in those infected with human immunodeficiency virus 1 (HIV-1) can speed up clinical...

Research on cells' power centers sheds light on new treatments.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Companies that create HIV-AIDS drugs now have key information that could assist in making new medications with fewer side effects. Researchers Henry Weiner, a professor of biochemistry at Purdue...

Therapeutic interruptions not effective.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Structured therapeutic interruptions (STI), long hailed as a way of reducing the side effects of long-term AIDS treatment, has been shown to be ineffective, according to a collaborative study between...

Antiretroviral therapy restores normal stem cell activity.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Antiretroviral therapy against HIV infection can restore normal hematopoietic stem cell activity, researchers in Italy say. "Haematological abnormalities...

Urine HIV-1 antibody test approved for life insurance screening.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corp. (CALY) , the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, announced that the West Virginia Office of the Insurance...

Autologous immunotherapy shown safe, effective.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- A clinical trial by researchers at the University of Medicine and Dentistry of New Jersey (UMDNJ) has shown a new autologous immunotherapy appears to be safe and effective treatment for controlling HIV....

Protease inhibitors compared in treatment-naive HIV/AIDS patients.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- A study presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego, California, showed that a regimen containing the investigational protease inhibitor...

U.S. patent granted covering key HIV target.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), announced the issue of a key U.S. patent in the area of HIV infection. The patent claims a specific GPCR sequence included in...

Viral resistance to entry inhibitors limited.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - HIV entry inhibitors are unlikely to engender drug-resistant viral mutants, researchers in the United States argue. "Two of the fusion inhibitors T-20 and...

HIV fusion inhibitors featured at ICAAC.(Interscience Conference on Antimicrobial Agents and Chemotherapy )
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Infectious disease specialists and scientists at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), heard new clinical data on a class of antiretrovirals that attacks HIV in a...

Compounds selectively target zinc finger protein specific to HIV in vitro.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Achillion Pharmaceuticals announced the development of a new class of compounds that inhibits a broad spectrum of drug-resistant HIV strains by targeting a novel virus protein. ACH-0100703, a...

Expanding multiresistant HIV population in need of new classes of drugs.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., a leading research and advisory firm focusing on pharmaceutical and healthcare issues, announced that the expanding multiresistant HIV population is in need of new classes of...

U.N. says AIDS in Asia may become worse than in Africa.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Outside of sub-Saharan Africa, more people live with HIV/AIDS in Asia than in any other region on earth, the head of the Joint UN Programme on HIV/AIDS (UNAIDS) says. "The epidemic in Asia...

Biopharmaceutical firm raises $3M.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced the completion of a $3 million institutional financing transaction that enables the clinical studies of Product R in Israel to move forward. The...

NIH grant helps initiate discovery program for new anti-HIV agents.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Invenux, Inc. announced that the company was awarded an SBIR grant of $100,000 from the U.S. National Institutes of Health to begin a drug-discovery program aimed at producing novel anti-HIV agents. ...

Company receives FDA approval for Versant HIV bDNA viral load system.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Bayer Diagnostics announced that it received U.S. Food and Drug Administration approval for Versant HIV-1 RNA 3.0 Assay (bDNA), its nucleic acid probe diagnostic assay for the direct quantification of...

Calypte Biomedical highlights its rapid HIV urine test at conference.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (CALY), the developer and marketer of the only two U.S. Food and Drug Administration (FDA) approved HIV-1 antibody tests for use with urine samples, shared information...

NIH intended for development of oral prophylactic/therapeutic HIV vaccine.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International (BDSI; BDSIW) announced that they have received a 2-year $600,000 National Institutes of Health (NIH) SBIR Grant to develop an oral form of a powerful HIV...

Opportunistic infection prophylaxis can be safely dropped after CD4 recovery.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Therapy to prevent opportunistic infection relapses in HIV patients is often unnecessary after antiretroviral treatment, researchers in Europe say. "The...

Viral inhibitors found in Chinese medical herbs.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Some Chinese herbs with traditional medical uses contain agents capable of blocking HIV activity, researchers report. "An increasing portion of patients...

Data demonstrate potent antiviral activity of new anti-HBV agent.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- An L-nucleoside antiviral agent, administered orally once daily, rapidly produced potent antihepatitis B virus (HBV) activity in patients chronically infected with HBV, reported Beth Israel Deaconess...

New avenue of HIV damage found.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Minnesota have discovered a new process by which HIV damages the immune system. They demonstrated that the portion of lymph nodes called the T-cell zone is...

Genetic findings in monkey herpes virus could aid research in human cancer.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- For the first time, scientists at the University of North Carolina (UNC) at Chapel Hill have discovered similar gene activity profiles between a herpes virus that affects rhesus macaque monkeys and a...

UMBI licenses HIV rat to Harlan.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- The patent for the first HIV-1 transgenic rat model has been licensed to Harlan Sprague Dawley, Inc., by the University of Maryland Biotechnology Institute. Scientists at the UMBI's Institute of...

Efforts to fight mother-to-child HIV transmission making an impact.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- The U.S. Congress has been told that existing public-private partnerships to prevent mother-to-child transmission (MTCT) of HIV in resource-poor countries have demonstrated success and can be rapidly...

Inhibitors of HIV replication identified using protein analysis technology.
November 4, 2002... 2002 NOV 4 - (NewsRx.com & NewsRx.net) -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH) announced an important discovery made using their proprietary protein analysis technology: the long-awaited identification of the CD8+ Antiviral Factor (CAF),...

Protein chimera can block viral replication.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have developed a chimeric protein that could form the basis of an effective genetic HIV treatment. "The human cyclin T1...

Novel method for viral reservoir eradication shows promise.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Europe have identified a novel treatment strategy for eradicating latent viral reservoirs in HIV patients. "The transcription factor...

Less expensive HIV progression test as effective as current tests in use.
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Researchers at the Johns Hopkins Bloomberg School of Public Health and the University of Zurich, Switzerland, have identified a test for monitoring the progression of HIV in the early stages of the...

Vitamin E can prevent infection-induced T-cell apoptosis.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Vitamin E may help protect T cells from the ravages of HIV infection, researchers in Germany report. "Expression of the CD95 (APO-1/Fas) ligand (CD95L) is...

Musculoskeletal disorders are often associated with HIV infection.
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- People infected with the human immunodeficiency virus (HIV) often experience a wide array of musculoskeletal symptoms secondary to the HIV infection. Some studies, for example, have shown that...

Annan calls for 50% increase in annual spending to fight HIV/AIDS.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- With funding for the global response to HIV/AIDS still grossly inadequate, United Nations Secretary-General Kofi Annan has called on countries to increase their spending by at least 50% for the next 3...

Fusion inhibitor granted priority review status by FDA.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Roche and Trimeris, Inc., (TRMS) announced that the U.S. Food and Drug Administration (FDA) has notified the companies that the New Drug Application (NDA) for Fuzeon (generic: enfuvirtide, formerly...

Pharmaceutical giant to let generic company manufacture its AIDS drug.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Pharmaceutical company Boehringer Ingelheim is allowing a South African generic drug manufacturer produce and sell the crucial AIDS drug nevirapine. Boehringer Ingelheim, an American company based...

Senegal's president sacks head of aid group for allegedly trafficking cheap AIDS drugs.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Senegal's president said he has dismissed the head of a humanitarian organization for his alleged role in trafficking cheap AIDS drugs that were meant for Africa but were sold off in Europe. ...

Oral medicines developer names expert in antiviral discovery and development as CEO.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Chimerix, Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, announced the appointment of George Painter, PhD, as company president and...

FDA approves Anti-R7V diagnostic kit as determinant for progression to AIDS.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- URRMA Biopharma, Inc., announced the U.S. Food and Drug Administration (FDA) has granted approval of URRMA's investigational device exemption (IDE) application for the Anti-R7V Diagnostic Kit. ...

AIDS blamed for mounting death toll in South African prisons.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Prisoners cram into cells soaked in grime and sweat. They share mattresses, tattoo needles and dirty razors. Rape is common. South Africa's prisons have become a breeding ground for the AIDS...

China on brink of explosive AIDS epidemic, Annan says.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Standing on the brink of an explosive AIDS epidemic, China must take action to prevent a massive further spread of the deadly disease, United Nations Secretary-General Kofi Annan said in October 2002,...

Irradiated meats may help protect immunosuppressed.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- 4WebMed, a company providing specialized nutritional products to patients suffering from chronic and acute illness, has added I-Care Foods irradiated meats to its product offerings. I-Care Foods...

ACE inhibitors could have broad applications.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- GenoMed, Inc., (OTC Pink Sheets: GMED), a St. Louis, Missouri-based medical genomics biotechnology company, announced that a research article documenting the many diseases which may benefit from its...

Novel noncytotoxic vaginal microbicide may help prevent HIV and other infections.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a promising microbicidal agent that may help prevent HIV and other sexually transmitted infections. ...

Fellowship funds study of dendritic cell role in immune response.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- The American Foundation for AIDS Research (amfAR) has awarded Emory microbiologist Sang-Moo Kang, PhD, a fellowship to study how dendritic cells might be used to improve the immune response against...

Patents awarded in U.S., Australia for multivalent antibody therapy.(Brief Article)
November 11, 2002... 2002 NOV 11 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced the issuance of U.S. Patent No. 6,458,933, which corresponds to Australia patent 742,626 issued May 2, 2002, covering new therapy agents for treating infectious...

Features common to "CD4-exploders" elucidated.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Italy have shed new light on HIV patients who show very rapid recovery of CD4+ T lymphocytes after starting antiretroviral therapy. ...

Ritonavir inhibits cellular efflux pump.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The HIV protease inhibitor ritonavir can suppress cellular activity linked to drug resistance, researchers in the United States report. "Efflux pumps...

Low-dose etoposide effective against high-risk Kaposi sarcoma.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a "safe and effective" treatment for HIV patients suffering from advanced Kaposi sarcoma. "Liposomal...

Epidemics could be eradicated with antiretroviral therapy.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Extensive use of existing treatments could make HIV the next smallpox, even without dramatic reductions in high-risk activity, researchers argue. "Current...

Nelfinavir raises sirolimus levels after liver transplantation.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The HIV protease inhibitor nelfinavir has dangerous interactions with drugs used to prevent liver graft rejection, researchers in the United States warn. ...

Interleukin-10 gene suppresses inflammation in opportunistic infection.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Interleukin-10 gene therapy can quell inflammation stemming from host response to Pneumocystis carinii infection. The news may be important for...

Study shows why some immune systems control HIV.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Scientists are beginning to change their thinking about why the immune systems of most people infected with HIV cannot control the spread of the virus while the immune systems of a rare group of...

Kalentra maker pleased with its "most-prescribed" status.(Brief Article)
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories' (NYSE:ABT) Kaletra (lopinavir/ritonavir) has become the most-prescribed protease inhibitor (PI) as part of a treatment regimen for HIV in the United States, the company announced....

License option agreement signed for cancer epitopes for ex vivo applications.(Brief Article)
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (NASDAQ:EPMN) a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body's immune system, announced that it had...

Medication reminders benefit treatment for AIDS patients.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- A new medication reminder prompts patients undergoing treatment for HIV to take their medications on time, as prescribed, according to feedback from physicians who have given reminders to their...

Official: Over half a million Cambodians to be AIDS victims by 2010.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- More than half a million Cambodians will suffer or die with AIDS by 2010 in what a senior health official has described as the country's new "killing field." Tia Phalla, secretary-general of...

Official: Russia could soon have 3-4 million people infected with HIV.(Brief Article)
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Russia's HIV-positive population could soon reach 3-4 million, given the country's skyrocketing infection rate, a top AIDS official said October 15, 2002, according to news reports. There are...

Company's third quarter revenue positively affected by HIV, HCV contracts.(hepatitis C virus)
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Boston Biomedica, Inc., (NASDAQ:BBII) reported its third quarter financial results. "Third quarter revenue increased 8.6%, driven primarily by strong activity in two service contracts related to...

Valtrex evaluated in HIV-infected patients.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Twice daily treatment with Valtrex (valacyclovir HCl) caplets is effective in suppressing genital herpes recurrences in HIV-infected patients, according to data presented at the Infectious Diseases...

Proteins may block HIV progression.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- In research that solves a 16-year medical mystery, scientists have identified a group of proteins that inhibit the progression of HIV in people who are resistant to the virus that causes AIDS. The...

NIH awards $1.95 million to study new treatments for drug side effects.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- A class of drugs known as protease inhibitors has dramatically improved the long-term survival of HIV-infected patients, but these drugs also pose a serious side effect called lipodystrophy, which can...

Mutagenesis can augment antiviral immunotoxin efficacy.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have devised a method to improve the activity of an immunotoxin that could be used to fight HIV infection. "HIV-infected...

Oral valganciclovir provides effective cytomegalovirus retinitis control.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel antiviral agent may make it easier to control cytomegalovirus (CMV) retinitis in AIDS patients, researchers say. Marisel Segarra-Newnham and...

Antiretroviral therapy restores some anti-TB immune activity.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Antiretroviral therapy (ART) for HIV infection restores some immune defense against tuberculosis, researchers say. Neil W. Schluger and colleagues at...

Foundation awards grant to Johns Hopkins to explore novel interventions.(Bill & Melinda Gates Foundation)
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- The Bill & Melinda Gates Foundation will contribute $3 million to the Johns Hopkins University School of Medicine for the development of community-based preventive strategies to control tuberculosis...

South Africa to cut taxes, spend more on AIDS.(Brief Article)
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- South Africa plans to cut taxes and increase its spending on AIDS and health care in its next budget, Finance Minister Trevor Manuel told Parliament in October 2002. The government also plans to...

Kent scientists to tackle potentially lethal fungal infections.(University of Kent, England)
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Scientists at the University of Kent, England, have been awarded a major grant to help in the fight against fungal infections, which can be potentially lethal for people whose immune systems are...

"Switch" immunomodulator reverses cancerous cell properties in vitro.
November 18, 2002... 2002 NOV 18 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that the company's peptide nucleic-acid immunomodulator, Product R, induces differentiation of the human promyelocytic leukemia cell line HL-60 in cell...

Myeloid-related proteins play key role in viral replication.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Canada have identified a set of cellular proteins that appear to play a key role in the process of HIV replication. "S100A8, S100A9, and...

Rapamycin inhibits viral replication.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Canada have discovered anti-HIV activity from a surprising source. "The immunosuppressive macrolide rapamycin is used in humans to prevent...

Perception of punishment undermines adherence.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Although advances in drug therapies have made HIV a manageable illness, patients' negative attitudes about the disease may undermine treatment, according to new research. Perhaps the most...

Multiple characteristics of HAART affect adherence described.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- The total number of pills that need to be taken every day in HAART therapy has the greatest impact on adherence of 10 characteristics studied, according to a survey of HIV-positive individuals, nearly...

Capsid protein tripeptides inhibit viral replication.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Sweden have identified a series of molecules that could act as novel and potent anti-HIV agents. "Capsid assembly during virus replication...

Multivitamins improve weight gain in HIV-infected, pregnant women.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Maternal HIV infection is a particular problem of sub-Saharan Africa, where more than 13 million women of childbearing age are infected. Pregnant women who are HIV-positive are at serious risk for...

European marketing authorization sought for Fuzeon, an HIV fusion inhibitor.(Brief Article)
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Roche and Trimeris, Inc., (TRMS) announced the submission of a Marketing Authorization Application to the European Union (E.U.) for Fuzeon (enfuvirtide), formerly known as T-20, for HIV-1 infection in...

Antiretrovirus biotech firm names senior management team, scientific advisory board.(Mymetics Corp. names Peter McCann, Joseph Mosca, Pierre-Francois Serres to board)
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Mymetics Corp. (MYMX), an international biotechnology firm focused on molecular mimicry and retroviral diseases, announced the appointment of its senior management team and scientific advisory board....

Richard G. Babbitt named director and chairman of the board of delipidation company.(Lipid Sciences Inc.)(Brief Article)
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Lipid Sciences, Inc., (LIPD) announced that Richard G. Babbitt has been elected to its board of directors and will serve as chairman. He will replace Christopher A. Marlett as chairman. Babbitt...

New dose of oral anabolic agent available.(Oxandrin now in 10mg strength)
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Bio-Technology General Corp. (BTGC) announced the availability of the new 10 mg strength of Oxandrin (oxandrolone, USP-CIII) a treatment for involuntary weight loss that can be associated with numerous...

AntiHIV agent active against malignant cells.(saquinavir)
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - An agent used to fight HIV infection may also be effective for uninfected cancer patients, researchers say. "Cancer cells frequently show high constitutive...

Plasma delipidation clinical trial put on hold for modifications.(Brief Article)
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Lipid Sciences, Inc., (LIPD) announced it voluntarily has paused its phase I human clinical trial. The company is reviewing the clinical protocol for the safety trial following a transitory...

Regular dental visits benefit oral health of HIV patients.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Regular dental visits may help maintain better oral health in people with the human immunodeficiency virus (HIV), suggests a study conducted by Delta Dental Plan of Minnesota researchers and published...

Update given for HIV, cystic fibrosis, and hepatitis drugs in clinical pipeline.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced decisions on three clinical development programs: * Chiron is stopping SILCAAT, a phase III study for recombinant human interleukin-2 (IL-2, aldesleukin) in...

Global Health Action makes inroads into China.
November 25, 2002... 2002 NOV 25 - (NewsRx.com & NewsRx.net) -- Global Health Action (GHA), a nonprofit health education and leadership and management development organization headquartered in Atlanta, Georgia, has been selected to assist the Chinese government in...